Indian J Pharm Close
 

Figure 1: Kaplan-Meier recurrence curves with the expression of p53 and eIF4E in recurrence and survival of head and neck and oral cancers. 0-Patients with negative immunostaining for (p53 and eIF4E). 1-Patients with positive immunostaining for (p53 and eIF4E). 2-Patients with eIF4E positive and p53-negative immunostaining. 3-Patients with p53-positive and eIF4E-negative immunostaining. Kaplan-Meier curves representing observed negative outcome in patients with surgically negative margins and various clinical scenarios of presentation with p53 and eIF4E. There was no statistically significance could be observed with the presence of individual markers, their combination, or absence

Figure 1: Kaplan-Meier recurrence curves with the expression of p53 and eIF4E in recurrence and survival of head and neck and oral cancers. 0-Patients with negative immunostaining for (p53 and eIF4E). 1-Patients with positive immunostaining for (p53 and eIF4E). 2-Patients with eIF4E positive and p53-negative immunostaining. 3-Patients with p53-positive and eIF4E-negative immunostaining. Kaplan-Meier curves representing observed negative outcome in patients with surgically negative margins and various clinical scenarios of presentation with p53 and eIF4E. There was no statistically significance could be observed with the presence of individual markers, their combination, or absence